-
Get Involved
Stay CloseParticipants in Airbnb's Open Homes program help nonprofit organizations to provide temporary lodging for cancer patients.
by Katherine Malmo
-
Our Own Words
People with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
-
A Researcher Attends a Conference, This Time as a Patient Advocate
My most meaningful moments at my first cancer research conference came from embracing my experience as a patient—not as a researcher.
by Jamie Aten
-
Advocacy Spotlight: A Mission to Bring Awareness
Minister and thyroid cancer survivor Thurselle C. Williams speaks at conferences and events about cancer awareness and, ultimately, healing following her 2016 diagnosis.
by Erin L. Boyle
-
Helping Cancer Survivors Sleep
A clinical trial comparing acupuncture and cognitive behavioral therapy found that they are both helpful for people who are experiencing sleep problems after cancer treatment.
by Cheryl Platzman Weinstock
-
Survivor Profile
Still in the GameESPN reporter Holly Rowe worked through melanoma treatment.
by Lindsey Konkel
-
Policy Matters
NIH-AACR Conference Examines Immunotherapy RisksThe meeting underscored the importance of NIH funding for cancer research.
by Elizabeth KS Barksdale, PhD
-
Get Involved
Patient NavigatorsPatient navigators can help cancer patients tackle the trickier points of accessing health care.
by Carisa D. Brewster
-
So You Want to Serve on a Scientific Review Panel?
Cancer patient advocates who review research proposals can provide valuable perspective.
by Bob Riter, Monica Vakiner and Carole Baas
-
New Rule Would Require Breast Density Disclosure
A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon